Human papillomavirus-related squamous cell carcinoma of the penis

Clinical trials for Human papillomavirus-related squamous cell carcinoma of the penis explained in plain language.

Never miss a new study

Get alerted when new Human papillomavirus-related squamous cell carcinoma of the penis trials appear

Sign up with your email to follow new studies for Human papillomavirus-related squamous cell carcinoma of the penis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for rare cancers: drug duo shows promise

Disease control Ongoing

This phase II trial tests whether combining two drugs, atezolizumab and bevacizumab, can shrink rare solid tumors like appendix cancer, anal cancer, and mesothelioma. About 133 participants with various rare cancers will receive the drugs intravenously. The goal is to see if the …

Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC

Human papillomavirus-related squamous cell carcinoma of the penis

Get alerted when new Human papillomavirus-related squamous cell carcinoma of the penis trials appear

New hope for rare cancers: drug duo shows promise